Difference between revisions of "Oxacillin"
Neil.m.young (talk | contribs) (Text replacement - "5 mg" to "5mg") |
Neil.m.young (talk | contribs) (Text replacement - "0 mg" to "0mg") |
||
| Line 7: | Line 7: | ||
===General=== | ===General=== | ||
*Mild-to-moderate infection | *Mild-to-moderate infection | ||
| − | **250- | + | **250-500mg IM/IV q4-6 hours |
*Severe infection | *Severe infection | ||
**1g IM/IV q4-6 hours | **1g IM/IV q4-6 hours | ||
| Line 24: | Line 24: | ||
===General=== | ===General=== | ||
*Mild-to-moderate | *Mild-to-moderate | ||
| − | ** | + | **50mg/kg/day IM/IV divided q6 hours |
**First Dose: 12.5mg/kg IM/IV x 1 | **First Dose: 12.5mg/kg IM/IV x 1 | ||
**Max: 4 g/day | **Max: 4 g/day | ||
*Severe | *Severe | ||
| − | ** | + | **100mg/kg/day IM/IV divided q4-6 hours |
**First Dose: 16.6-25mg/kg IM/IV x 1 | **First Dose: 16.6-25mg/kg IM/IV x 1 | ||
**Max: 12 g/day | **Max: 12 g/day | ||
===Community-Acquired [[Pneumonia]] (>3 Months)<ref>IDSA/PIDS, 2011</ref>=== | ===Community-Acquired [[Pneumonia]] (>3 Months)<ref>IDSA/PIDS, 2011</ref>=== | ||
| − | *150- | + | *150-200mg/kg/day divided q6-8 hours |
*First Dose: 37.5-66.6 mg/kg IV x 1 | *First Dose: 37.5-66.6 mg/kg IV x 1 | ||
*For [[MSSA]] | *For [[MSSA]] | ||
Revision as of 08:06, 21 July 2016
Contents
General
- Type: Anti-Staphylococcal Penicillin
- Dosage Forms: IM; IV
- Common Trade Names:
Adult Dosing
General
- Mild-to-moderate infection
- 250-500mg IM/IV q4-6 hours
- Severe infection
- 1g IM/IV q4-6 hours
Endocarditis
- 2g IV q4 hours + gentamicin
Prosthetic Joint Infection
- 2g IV q4 hours + rifampin
MSSA
- 2g IV q4 hours
- Examples: brain abscess, bursitis, erysipelas, mastitis, mastoiditis, osteomyelitis, perinephric abscess, pneumonia, pyomyositis, Scalded Skin Syndrome, Toxic Shock Syndrome
Pediatric Dosing
General
- Mild-to-moderate
- 50mg/kg/day IM/IV divided q6 hours
- First Dose: 12.5mg/kg IM/IV x 1
- Max: 4 g/day
- Severe
- 100mg/kg/day IM/IV divided q4-6 hours
- First Dose: 16.6-25mg/kg IM/IV x 1
- Max: 12 g/day
Community-Acquired Pneumonia (>3 Months)[1]
- 150-200mg/kg/day divided q6-8 hours
- First Dose: 37.5-66.6 mg/kg IV x 1
- For MSSA
Special Populations
- Pregnancy Rating: B
- Lactation: Use caution
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Fever
- Rash
- Nausea and Vomiting
- Diarrhea
- Eosinophilia
- Leukopenia
- Neutropenia
- Thrombocytopenia
- Agranulocytosis
- Hepatotoxicity
- AST increased
- Acute interstitial nephritis
- Hematuria
- Serum sickness-like reactions
Common
Pharmacology
- Half-life: 20-60 minutes (prolonged in neonates and renal impairment)
- Metabolism:
- Excretion:
- Mechanism of Action:
Antibiotic Sensitivities[2]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia